Obesity and related cardiometabolic conditions are key targets for the development of new therapeutics. Biomarkers associated with obesity and related metabolic conditions, include adipokines, inflammatory markers and metabolic markers.
Rules-Based Medicine, an IQVIA business, performs multiplexed Luminex-based assays and ultrasensitive Simoa-based assays to help evaluate drug candidates targeting obesity and cardiometabolic conditions.
Download Document